Literature DB >> 16377662

Quinolones for treatment of human brucellosis: critical review of the evidence from microbiological and clinical studies.

Matthew E Falagas1, Ioannis A Bliziotis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16377662      PMCID： PMC1346783          DOI： 10.1128/AAC.50.1.22-33.2006

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  61 in total

1.  In vitro activities of new quinolones against Brucella melitensis isolated in a tertiary-care hospital in Turkey.

Authors:  S Kocagöz; M Akova; B Altun; D Gür; G Hasçelik
Journal:  Clin Microbiol Infect       Date:  2002-04       Impact factor: 8.067

2.  Childhood brucellosis: a study of 102 cases.

Authors:  Y A al-Eissa; A M Kambal; M N al-Nasser; S A al-Habib; I M al-Fawaz; F A al-Zamil
Journal:  Pediatr Infect Dis J       Date:  1990-02       Impact factor: 2.129

3.  Osteoarthricular involvement of brucellosis in Turkey.

Authors:  Y Taşova; N Saltoğlu; G Sahin; H S Aksu
Journal:  Clin Rheumatol       Date:  1999       Impact factor: 2.980

4.  Antibacterial activity of lomefloxacin against Brucella melitensis.

Authors:  S M Qadri; S al-Sedairy; Y Ueno
Journal:  Diagn Microbiol Infect Dis       Date:  1990 May-Jun       Impact factor: 2.803

5.  Efficacy of rifampicin plus doxycycline versus rifampicin plus quinolone in the treatment of brucellosis.

Authors:  Nese Saltoglu; Yesim Tasova; Ayse S Inal; Tugba Seki; Hasan S Aksu
Journal:  Saudi Med J       Date:  2002-08       Impact factor: 1.484

6.  In vitro antimicrobial susceptibility of Brucella species.

Authors:  Nurcan Baykam; Harika Esener; Onder Ergönül; Sebnem Eren; Aysel K Celikbas; Başak Dokuzoguz
Journal:  Int J Antimicrob Agents       Date:  2004-04       Impact factor: 5.283

7.  In vitro activity of lomefloxacin, a difluorinated quinolone, compared with other antimicrobials.

Authors:  S M Qadri; G C Lee; M E Ellis
Journal:  Chemotherapy       Date:  1991       Impact factor: 2.544

8.  Susceptibility of Salmonella typhi and Brucella melitensis to the new fluoroquinolone rufloxacin (MF 934).

Authors:  S M Qadri; A Ayub; Y Ueno; H Saldin
Journal:  Chemotherapy       Date:  1993 Sep-Oct       Impact factor: 2.544

9.  Neurobrucellosis in an endemic area of brucellosis.

Authors:  Hürrem Bodur; Ayse Erbay; Esragül Akinci; Aylin Colpan; Mustafa A Cevik; Neriman Balaban
Journal:  Scand J Infect Dis       Date:  2003

10.  Brucellar spondylitis: a rare cause of spinal cord compression.

Authors:  B Sonel Tur; N Suldur; S Ataman; E A Ozturk; A Bingol; M B Atay
Journal:  Spinal Cord       Date:  2004-05       Impact factor: 2.772
View more
  19 in total

1.  Antimicrobial susceptibility of Brucella melitensis isolates in Peru.

Authors:  Ryan C Maves; Rosa Castillo; Alfredo Guillen; Benjamin Espinosa; Rina Meza; Nereyda Espinoza; Gladys Núñez; Luis Sánchez; Jesús Chacaltana; David Cepeda; Sofía González; Eric R Hall
Journal:  Antimicrob Agents Chemother       Date:  2011-01-03       Impact factor: 5.191

2.  Acute prostatitis as an uncommon presentation of brucellosis.

Authors:  Elif Hakko; Melda Ozdamar; Salih Turkoglu; Semra Calangu
Journal:  BMJ Case Rep       Date:  2009-05-25

Review 3.  The current therapeutical strategies in human brucellosis.

Authors:  Mile Bosilkovski; Fariba Keramat; Jurica Arapović
Journal:  Infection       Date:  2021-03-01       Impact factor: 3.553

Review 4.  Review of brucellosis in Nepal.

Authors:  Krishna Prasad Acharya; Krishna Kaphle; Kshitiz Shrestha; Bruno Garin Bastuji; Henk L Smits
Journal:  Int J Vet Sci Med       Date:  2016-12-16

5.  Effect of carbon dioxide on broth microdilution susceptibility testing of Brucella spp.

Authors:  David R Lonsway; Laura A Jevitt; James R Uhl; Franklin R Cockerill; Mary E Anderson; Maureen M Sullivan; Barun K De; Jonathan R Edwards; Jean B Patel
Journal:  J Clin Microbiol       Date:  2009-12-23       Impact factor: 5.948

Review 6.  Systematic review and meta-analysis of randomized clinical trials in the treatment of human brucellosis.

Authors:  Julián Solís García del Pozo; Javier Solera
Journal:  PLoS One       Date:  2012-02-29       Impact factor: 3.240

7.  A 26-year-old man with sternoclavicular arthritis.

Authors:  Christian Gutierrez Ruiz; J Jaime Miranda; Georgios Pappas
Journal:  PLoS Med       Date:  2006-08       Impact factor: 11.069

Review 8.  Host-Brucella interactions and the Brucella genome as tools for subunit antigen discovery and immunization against brucellosis.

Authors:  Gabriel Gomez; Leslie G Adams; Allison Rice-Ficht; Thomas A Ficht
Journal:  Front Cell Infect Microbiol       Date:  2013-05-16       Impact factor: 5.293

9.  The Antibacterial Activity of Selected Labiatae (Lamiaceae) Essential Oils against Brucella melitensis.

Authors:  Ayman Al-Mariri; Mazen Safi
Journal:  Iran J Med Sci       Date:  2013-03

10.  Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations.

Authors:  Javier Ariza; Mile Bosilkovski; Antonio Cascio; Juan D Colmenero; Michael J Corbel; Matthew E Falagas; Ziad A Memish; Mohammad Reza Hasanjani Roushan; Ethan Rubinstein; Nikolaos V Sipsas; Javier Solera; Edward J Young; Georgios Pappas
Journal:  PLoS Med       Date:  2007-12       Impact factor: 11.069
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.